Ivermectin vs Merck’s new early treatment drug

Click to visit the TBP Store for Great TBP Merchandise

The Extraordinary Hypocrisy of Molnupiravir

Guest Post by Dr. James Lyons-Weiler

The Representation of Merck’s Molnupiravir as a “Game Changer” Only Underscores a Bias – And Merck Has Other Data It Is Not Sharing

Trigger alert: This article may upset those who care about other human beings.

Molnupiravir (mull-noo-’peer-aveer) is the talk of the town, belle of the ball in the press. “Game changer” is the word on the street, according to a message to Science Insider:

“Molnupiravir is unquestionably a game changer! The large effect size, and the ease of administration change the paradigm of mild COVID-19 treatment with a potential to reduce COVID-19 death rates.” See: Science Magazine

The hype even included Fauci going on in an interview about how the idea that molnupiravir is so effective that the vaccine won’ t be needed.

“That’s such a false narrative” Fauci aped at the camera.

What’s all the excitement & hype about?

Continue reading “The Extraordinary Hypocrisy of Molnupiravir”

CDC, FDA Prepare Mass Distribution of a Merck/Sanofi Six-in-One Vaccine for Kids, Turning Blind Eye to Safety Signals

Via Children’s Health Defense

There are numerous warning signs that potent all-in-one vaccines are too much for immature immune systems to handle.

Since the mid-1980s, the number of childhood shots on the Centers for Disease Control and Prevention (CDC) vaccine schedule has more than quadrupled. When parents express reluctance about turning their little ones into perpetual pin cushions, drug makers and doctors have a ready answer — combination vaccines that “simplify” the schedule by decreasing the number of injections administered.

This month marks the U.S. launch of the Merck/Sanofi joint-venture vaccine, Vaxelis, a six-in-one (hexavalent) combination vaccine that contains diphtheria, tetanus and acellular pertussis (DTaP) components as well as components said to protect against polio, Haemophilus influenzae type b (Hib) and hepatitis B.

Continue reading “CDC, FDA Prepare Mass Distribution of a Merck/Sanofi Six-in-One Vaccine for Kids, Turning Blind Eye to Safety Signals”